Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026)
Enovis (ENOV) reported Net Income towards Common Stockholders of -$39000.0 for Q2 2026, up 68.8% year-over-year from -$23104.3 in Q2 2025, and up 97.64% quarter-over-quarter from -$1.7 million in Q4 2025.
Enovis (ENOV) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$39000.0 in Q2 2026.
- Net Income towards Common Stockholders for Q2 2026 came in at -$39000.0, up 68.8% year-over-year; the trailing twelve-month figure through Apr 2026 was -$1.8 million (down 173.63% YoY), and the FY2025 annual result was -$1.9 million, down 173.39% from the prior year.
- Net Income towards Common Stockholders rose to -$39000.0 in Q2 2026 per ENOV's latest filing, from -$1.7 million in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $16.6 million in Q3 2023 and troughed at -$43.7 million in Q3 2022.
- A 5-year average of $556437.5 and a median of -$39500.0 in 2025 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders jumped 3450.0% in 2024, then plunged 487.56% in 2025.
- A 5-year view of Net Income towards Common Stockholders shows it stood at $16.3 million in 2022, then sank by 99.93% to $12000.0 in 2023, then jumped by 3450.0% to $426000.0 in 2024, then sank by 487.56% to -$1.7 million in 2025, then surged by 97.64% to -$39000.0 in 2026.
- Business Quant data shows ENOV's Net Income towards Common Stockholders at -$39000.0 in Q2 2026, -$1.7 million in Q4 2025, and -$40000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 187,319.30 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | -39,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -39,000.00 |
| Dec 31, 2025 | -1.65 Mn |
| Oct 3, 2025 | -40,000.00 |
| Jul 4, 2025 | -93,000.00 |
| Apr 4, 2025 | -125,000.00 |
| Dec 31, 2024 | 426,000.00 |
| Sep 27, 2024 | 2.24 Mn |
| Jun 28, 2024 | -68,000.00 |
| Dec 31, 2023 | 12,000.00 |
| Sep 29, 2023 | 16.61 Mn |
| Jun 30, 2023 | 4.80 Mn |
| Mar 31, 2023 | -312,000.00 |
| Dec 31, 2022 | 16.27 Mn |
| Sep 30, 2022 | -527,000.00 |
| Jul 1, 2022 | -43.67 Mn |
| Apr 1, 2022 | 15.07 Mn |
| Dec 31, 2021 | 14.17 Mn |
| Oct 1, 2021 | 25.85 Mn |
| Jul 2, 2021 | 28.64 Mn |
| Apr 2, 2021 | 19.07 Mn |